PolyPid (PYPD) awards director 9,132 stock options vesting through 2030

Rhea-AI Filing Summary

PolyPid Ltd. reported that director Itzhak Krinsky received a grant of stock options for 9,132 Ordinary Shares at an exercise price of $4.4600 per share. The options vest on a quarterly basis from July 15, 2026 until April 15, 2030 and expire on July 15, 2036.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Krinsky Itzhak

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock option (right to buy) F1	9,132	$4.46	$41K

Holdings After Transaction: Stock option (right to buy) — 9,132 shares (Direct)

Footnotes (1)

1. F1. The options vest on a quarterly basis beginning July 15, 2026 until April 15, 2030.

Key Figures

Option shares granted: 9132.0000 shares Exercise price: $4.4600 per share Option expiration date: 2036-07-15 +2 more

5 metrics

Option shares granted 9132.0000 shares Stock option grant to director Itzhak Krinsky

Exercise price $4.4600 per share Conversion or exercise price of the stock options

Option expiration date 2036-07-15 Expiration date of the granted stock options

Vesting start date July 15, 2026 Options vest on a quarterly basis beginning this date

Vesting end date April 15, 2030 Quarterly vesting continues until this date

Key Terms

Stock option (right to buy), Ordinary Shares, conversion_or_exercise_price, vest on a quarterly basis

4 terms

Stock option (right to buy) financial

"security_title: "Stock option (right to buy)""

Ordinary Shares financial

"underlying_security_title: "Ordinary Shares""

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

conversion_or_exercise_price financial

"Field "conversion_or_exercise_price": "4.4600""

vest on a quarterly basis financial

"The options vest on a quarterly basis beginning July 15, 2026"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/17/2026 - 04:02 PM Accepted by SEC EDGAR 07/17/2026 - 04:02 PM Learn about SEC filing dates

FAQ

What stock option grant did PolyPid (PYPD) report for director Itzhak Krinsky?

PolyPid disclosed that director Itzhak Krinsky received 9,132 stock options for Ordinary Shares with an exercise price of $4.4600 per share. The options were granted on July 15, 2026 and are reported as directly owned by him.

What is the exercise price of the PolyPid (PYPD) stock options granted to Itzhak Krinsky?

The stock options granted to Itzhak Krinsky carry an exercise price of $4.4600 per share. This is the price at which he may purchase Ordinary Shares when the options become exercisable over the vesting period.

How do the PolyPid (PYPD) options granted to Itzhak Krinsky vest over time?

The options granted to Itzhak Krinsky vest on a quarterly basis beginning July 15, 2026 until April 15, 2030. This schedule gradually makes portions of the 9,132 options exercisable rather than all at once.

When do the PolyPid (PYPD) stock options granted to Itzhak Krinsky expire?

The stock options granted to Itzhak Krinsky expire on July 15, 2036. After this expiration date, any unexercised portion of the 9,132 options will no longer be exercisable for Ordinary Shares.

Was the PolyPid (PYPD) option grant to Itzhak Krinsky reported as a trading plan transaction?

No. The Form 4 indicates the Rule 10b5-1 trading plan checkbox is not checked. The transaction is reported as a grant or award (code A), not as activity under a pre-arranged trading plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Krinsky Itzhak

(Last) (First) (Middle)

C/O POLYPID LTD.

18 HASIVIM STREET ISRAEL

(Street)

PETACH TIKVA 495376

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
PolyPid Ltd. [ PYPD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock option (right to buy)	$4.46	07/15/2026		A		9,132		10/15/2026(1)	07/15/2036	Ordinary Shares	9,132	$4.46	9,132	D

Explanation of Responses:

1. The options vest on a quarterly basis beginning July 15, 2026 until April 15, 2030.

	/s/ Krinsky Itzhak	07/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)